Axillary Management of Stage II/III Breast Cancer Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-positive) and CALGB 40603 (Triple-negative)

OBJECTIVES: Management of the axilla in stage II/III breast cancer undergoing neoadjuvant systemic therapy (NST) is controversial. To understand current patterns of care, we collected axillary data from two NST trials: HER2-positive (CALGB40601) and triple-negative (CALGB40603). METHODS: Axillary ev...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Coll Surg
Main Authors: Ollila, David W, Cirrincione, Constance T, Berry, Donald A, Carey, Lisa A, Sikov, William M, Hudis, Clifford A, Winer, Eric P, Golshan, Mehra
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5616181/
https://ncbi.nlm.nih.gov/pubmed/28089784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jamcollsurg.2016.12.036
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados